Carregant...
HIV-specific CD8(+) T cells and HIV eradication
After the success of combination antiretroviral therapy (cART) to treat HIV infection, the next great frontier is to cure infected persons, a formidable challenge. HIV persists in a quiescent state in resting CD4(+) T cells, where the replicative enzymes targeted by cART are not active. Although low...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4731167/ https://ncbi.nlm.nih.gov/pubmed/26731469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80566 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|